SIRNAOMICS-B (02257) completes issuance of 2.5 million new shares.

date
18:05 08/03/2026
avatar
GMT Eight
Sinopharm Group -B (02257) announced that the subscription agreement A was partially completed on March 7, 2026, and 2.5 million new shares were issued to subscriber A at a subscription price of HK$12.00 per share (completion of subscription matter A).
SIRNAOMICS-B (02257) announced that Subscription Agreement A was partially completed on March 7, 2026, issuing 2.5 million new shares to Subscriber A at a price of HK$12 per share (partial completion of Subscription A). After friendly and honest negotiations, the Company and Subscriber A have agreed to terminate the subscription of the remaining 9.068 million shares (remaining shares of Subscription A) on March 7, 2026. After this termination, all rights and obligations under the agreement will be void, and neither party may make any claims against the other regarding Subscription Agreement A. The Board of Directors believes that terminating the subscription of the remaining shares of Subscription A will not have any significant adverse impact on the Company's existing business, operations, or financial condition.